Women who develop preeclampsia during pregnancy are four times more likely to develop
cardiovascular disease later in life, even if they are otherwise healthy. The reason why this
occurs may be related to lasting blood vessel damage after the pregnancy but there are
currently no specific treatment strategies to prevent this disease progression. This study
addresses this public health issue by examining whether starting low dose aspirin therapy
after pregnancy is an effective treatment for lasting blood vessel damage in order to inform
better clinical management of cardiovascular disease risk in women who have had preeclampsia.